Anzeige
Mehr »
Login
Mittwoch, 30.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Desert Gold Ventures: Diese Goldaktie ist ein TOP-Übernahmekandidat
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2APAB | ISIN: SE0008348262 | Ticker-Symbol: 5JD
Frankfurt
29.10.24
20:53 Uhr
0,068 Euro
+0,014
+24,91 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
EXPRES2ION BIOTECH HOLDING AB Chart 1 Jahr
5-Tage-Chart
EXPRES2ION BIOTECH HOLDING AB 5-Tage-Chart

Aktuelle News zur EXPRES2ION BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
00:01XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 30.10.202458The following instruments on XETRA do have their first trading 30.10.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 30.10.2024 Aktien 1 PLTRKPL00014 Trakcja S.A. 2 GB00BPVDXX64...
► Artikel lesen
DiXFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 29.10.2024182The following instruments on Boerse Frankfurt do have their last trading day on 29.10.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 29.10.2024.ISIN NameNO0012547308 STANDARD...
► Artikel lesen
DiXFRA ISIN CHANGE39Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenNO0012547308 Standard Supply AS 29.10.2024 NO0013384651 Standard Supply AS 30.10.2024 Tausch 100:1US49372L1008 Kezar...
► Artikel lesen
DiNasdaq Stockholm AB: Reverse Split and Change of ISIN for ExpreS2ion Biotech Holding AB117Referring to the bulletin from ExpreS2ion Biotech Holding AB's extraordinary general meeting, held on 21 October 2024, the company will carry out a reverse stock split in relations 1:40. The share will...
► Artikel lesen
DoExpreS2ion Biotech Holding AB: The Board of Directors of ExpreS2ion Biotech Holding AB (publ) has resolved on the record date for the reverse share split172Hørsholm, Denmark, 24 October 2024 - At the Extraordinary General Meeting of ExpreS2ion Biotech Holding AB (publ) ("ExpreS2ion" or the "Company") on 21 October 2024, it was resolved on a reverse share...
► Artikel lesen
21.10.ExpreS2ion Biotech Holding AB: Bulletin from the Extraordinary General Meeting of ExpreS2ion Biotech Holding AB (publ)90Today, on 21 October 2024, ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") has held an Extraordinary General Meeting 2024 (the "EGM"). Notice of the EGM and complete proposals for resolutions...
► Artikel lesen
16.10.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion and Serum Institute of India have entered in a term sheet regarding proposed development and commercialisation of novel malaria vaccines3
19.09.EXPRES2ION BIOTECHNOLOGIES: Notice to attend the Extraordinary General Meeting in ExpreS2ion Biotech Holding AB (publ)1
10.09.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion to present in upcoming investor events1
23.08.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion announces publication of sponsored research reports2
15.08.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion announces financial results for the second quarter of 20242
06.08.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion submits Clinical Trial Application (CTA) to conduct Phase I study of ES2B-C001, an innovative therapeutic breast cancer vaccine2
24.07.Nasdaq Stockholm AB: New equity right for trading, ExpreS2ion Biotech Holding AB TO11213At the request of ExpreS2ion Biotech Holding AB, equity rights will be traded on First North Growth Market as from July 25, 2024. Security name: ExpreS2ion Biotech Holding AB TO11 -------------------------------------------------- Short...
► Artikel lesen
24.07.Nasdaq Stockholm AB: New equity right for trading, ExpreS2ion Biotech Holding AB TO10218At the request of ExpreS2ion Biotech Holding AB, equity rights will be traded on First North Growth Market as from July 25, 2024. Security name: ExpreS2ion Biotech Holding AB TO10 -------------------------------------------------- Short...
► Artikel lesen
05.07.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion resolves on a directed issue of units to guarantors in connection with the completed rights issue2
03.07.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion announces U.S. patent issue notification for glyco-engineered immunization antigens2
01.07.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion announces final outcome of its rights issue2
26.06.EXPRES2ION BIOTECHNOLOGIES: Rights issue subscription period ending 27 June 2024; subscription possible via form2
24.06.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion announces poster presentation on the use of glycoengineered Drosophila S2 cells for production of highly immunogenic antigens at the ESACT meeting3
21.06.EXPRES2ION BIOTECHNOLOGIES: Publication of clinical Phase Ib trial data for the adjuvanted RH5.1 blood-stage malaria vaccine1
Seite:  Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1